Alpha Cognition (ACOG) Research & Development (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Research & Development came in at $569749.0 in Q4 2025, down 45.24% year-on-year from $1.0 million in Q4 2024, and down 0.67% quarter-over-quarter from $573592.0 in Q3 2025.
Alpha Cognition (ACOG) Research & Development (2023 - 2025) Analysis & Trends
Alpha Cognition's Research & Development history runs 3 years deep, the most recent figure standing at $569749.0 for Q4 2025.
- On a quarterly basis, Research & Development fell 45.24% year-over-year to $569749.0 in Q4 2025; TTM through Dec 2025 was $1.9 million, a 52.35% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 52.35% from the prior year.
- Research & Development slipped to $569749.0 in Q4 2025 per ACOG's latest filing, from $573592.0 in the prior quarter.
- Across five years, Research & Development topped out at $1.4 million in Q3 2023 and bottomed at $317120.0 in Q2 2025.
- The 3-year median for Research & Development is $967200.0 (2024), against an average of $870401.7.
- Across the five-year window, Research & Development decreased 6.27% in 2024 and slumped 67.21% in 2025, its largest moves.
- Year by year, Research & Development stood at $1.1 million in 2023, then declined by 6.27% to $1.0 million in 2024, then plunged by 45.24% to $569749.0 in 2025.
- Per Business Quant, the three latest ACOG Research & Development figures stand at $569749.0 (Q4 2025), $573592.0 (Q3 2025), and $317120.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | 569,749.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 569,749.00 |
| Sep 30, 2025 | 573,592.00 |
| Jun 30, 2025 | 317,120.00 |
| Mar 31, 2025 | 407,511.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 996,029.00 |
| Jun 30, 2024 | 967,200.00 |
| Mar 31, 2024 | 916,716.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.25 Mn |